Publication | Closed Access

Beneficial effect of interferon-β treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-β injection

InflammationClinical ImmunologyCytokineAutoimmune DiseaseMedicineBeneficial EffectImmunologyImmune RegulationSerum Il-6 LevelImmunologic DiseaseNeurologyImmune FunctionMultiple SclerosisNeuroimmunology